Table 2.
Trait | Males (N = 216) | Females (N = 151) | ||||
---|---|---|---|---|---|---|
Controls (N = 119) | Cases (N = 97) | P | Controls (N = 84) | Cases (N = 67) | P | |
Age (years) | 58.68 ± 12.01 | 64.15 ± 10.71 | <10 −4 | 63.38 ± 12.16 | 61.28 ± 11.00 | 0.27 |
Body mass index (kg/m2) | 24.80 ± 3.41 | 25.23 ± 2.79 | 0.32 | 25.64 ± 3.68 | 24.93 ± 3.66 | 0.24 |
Hypertension, n (%) | 0 (0.0 %) | 65 (67.01 %) | <10 −4 | 13 (15.48 %) | 18 (26.87 %) | 0.09 |
Diabetes mellitus, n (%) | 0 (0.0 %) | 39 (58.21 %) | <10 −4 | 10 (11.90 %) | 20 (29.85 %) | 0.006 |
Plasma glucose (mmol/l) | 4.56 ± 0.71 | 5.02 ± 3.09 | 0.12 | 4.37 ± 0.70 | 4.71 ± 2.13 | 0.17 |
LDL cholesterol (mmol/l) | 2.55 ± 1.24 | 3.13 ± 1.14 | 5E−04 | 2.54 ± 1.14 | 3.49 ± 1.49 | <10 −4 |
Triglycerides (mmol/l) | 1.24 ± 0.73 | 1.21 ± 0.65 | 0.75 | 1.33 ± 0.47 | 1.47 ± 0.92 | 0.23 |
HDL cholesterol (mmol/l) | 0.83 ± 0.22 | 0.84 ± 0.27 | 0.76 | 0.82 ± 0.44 | 0.79 ± 0.26 | 0.62 |
Non enzymatic antioxidant parameters | ||||||
Uric Acid (µmol/l) | 332.3 ± 92.90 | 342.38 ± 154.27 | 0.55 | 285.21 ± 83.71 | 326.27 ± 138.95 | 0.03 |
Total bilirubin (µmol/l) | 18.39 ± 4.21 | 8.11 ± 4.58 | <10 −4 | 15.89 ± 5.49 | 7.62 ± 5.04 | <10 −4 |
Direct bilirubin (µmol/l) | 7.93 ± 3.14 | 2.71 ± 1.95 | <10 −4 | 6.83 ± 3.72 | 2.07 ± 1.74 | <10 −4 |
Albumin (g/l) | 41.72 ± 4.23 | 40.65 ± 4.30 | 0.07 | 41.75 ± 7.83 | 40.95 ± 4.10 | 0.45 |
Iron (µmol/l) | 18.47 ± 4.54 | 16.20 ± 3.90 | 10 −4 | 17.93 ± 5.41 | 16.60 ± 3.10 | 0.075 |
Enzymatic antioxidant parameters | ||||||
SOD activity, (U/gHb) | 1321.4 ± 204.8 | 1089.2 ± 219.7 | <10 −4 | 1463.8 ± 233.4 | 1166.5 ± 213.9 | <10 −4 |
TAS (mmol/l) | 1.63 ± 0.271 | 1.40 ± 0.232 | <10 −4 | 1.70 ± 0.267 | 1.38 ± 0.289 | <10 −4 |
SOD genotypes (%), n (CC/CT/TT) | 31.93/45.38/22.69 % | 23.71/37.11/39.18 % | 0.03 | 17.86/55.95/26.19 % | 23.88/52.24/23.88 % | 0.66 |
38/54/27 | 23/36/38 | 15/47/22 | 16/35/16 |
*P < 0.05 was required for statistical significance